HAL vs TNXP · P/E 9.3, $19.05B cap vs rev $10.1M
Halliburton Company (HAL) versus Tonix Pharmaceuticals Holding Corp (TNXP) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Tonix Pharmaceuticals Holding Corp (TNXP) is a biotechnology company listed on NASDAQ.
HAL does not have a complete income-statement cache yet.
Latest reported TNXP revenue for 2024-12-31 was $10.1M. Net income was -$130.0M. Revenue was up 29.9% from 2023-12-31 to 2024-12-31. TNXP currently screens at market cap $194.5M.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. TNXP currently screens at market cap $194.5M.
Not investment advice. Open the HAL and TNXP stock pages for the full models.
Not investment advice.